Should I buy C.H. Robinson (CHRW) stock or is it too late?

C.H. Robinson · Industrials · price $151

See the full C.H. Robinson (CHRW) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Truist Securities — 80% of its targets hit on this sector (205 calls tested). It aims for $215 (+42 %), call made on July 16, 2026, maturing on July 16, 2027 (43 d ago).

The 13 reliable analysts $203+34 %

The 6 other firms $213+41 %

How to read it: the 13 reliable firms are not filtered by optimism — 11 aim above the price, 2 below, hence their $203 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on C.H. Robinson

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Raymond James	100 %	+63.0 %	6	$203 +34%
Susquehanna	60 %	+34.8 %	10	$226 +50%
Citigroup	70 %	+34.5 %	10	$196 +30%
Benchmark	60 %	+24.3 %	5	$205 +36%
Stifel	71 %	+21.5 %	7	$225 +49%
UBS	67 %	+21.5 %	15	$230 +52%
Wolfe Research	60 %	+19.6 %	5	$115 -24%
B of A Securities	58 %	+10.9 %	19	$219 +45%

In short — Should you invest in C.H. Robinson? Is it too late, still worth it? Analysts are fairly positive (74% buy, median target $210, i.e. +39%), and the most reliable on CHRW targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

74% of analysts rate it a buy (Buy consensus, 19 ratings) — a sign of market conviction.
Median price target $210, i.e. +39% from the current price ($151).
The most reliable firm on CHRW, Raymond James (100% hit rate, 6 scored calls), targets $203 (call made on July 2, 2026, maturing on July 2, 2027) (+34%) in its most recent call.
8 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 19 ratings, 4 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on CHRW

Median target $210 (+39%) · 19 ratings · Buy consensus

Strong Buy00%

Buy1474%

Hold421%

Sell15%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in C.H. Robinson now?

We won't decide for you. The facts: 74% of analysts rate it a buy, median target $210 (+39%), and Raymond James (most reliable on CHRW, 100%) targets $203. Weigh that against valuation (P/E ~29). This is not personalized advice.

Is it too late to invest in C.H. Robinson?

Not according to analysts: the median target ($210) is still +39% above the current price ($151) (most reliable on CHRW: Raymond James, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is C.H. Robinson still worth investing in?

It depends on the gap between the price ($151) and its estimated value: analysts target $210 on median (+39%), with 74% buys (most reliable on CHRW: Raymond James, 100%). Cross-check with their real reliability on CHRW and the cautions above. Information, not advice.

What's the main risk in buying CHRW?

The consensus is not unanimous: of 19 ratings, 4 are neutral and 1 is a sell.

→ Go deeper: the full C.H. Robinson profile (consensus, analyst reliability, price target, performance).